Search
Fungal Identification (19th - 21st December 2023)
19/12/2023
Specialist practical tuition in the identification of pathogenic fungi for biomedical scientists, clinical scientists and FRCpath candidates.
Fungal Identification (21st - 23rd November 2023)
21/11/2023
Specialist practical tuition in the identification of pathogenic fungi for biomedical scientists, clinical scientists and FRCpath candidates.
Fungal Identification (21st - 23rd November 2023)
21/11/2023
Specialist practical tuition in the identification of pathogenic fungi for biomedical scientists, clinical scientists and FRCpath candidates.
Fungal Identification (28th - 30th November 2023)
28/11/2023
Specialist practical tuition in the identification of pathogenic fungi for biomedical scientists, clinical scientists and FRCpath candidates.
Fungal Identification (28th - 30th November 2023)
28/11/2023
Specialist practical tuition in the identification of pathogenic fungi for biomedical scientists, clinical scientists and FRCpath candidates.
Fungal Identification (5th - 7th December 2023)
05/12/2023
Specialist practical tuition in the identification of pathogenic fungi for biomedical scientists, clinical scientists and FRCpath candidates.
Reticulin Staining – Its Significance in Cancer Diagnosis Focussed Webinar
15/11/2023
This session is a simple exploration of why reticulin stains are required, what they tell pathologist and how that aids in diagnosing cancers.
Transmission Electron Microscopy Webinar 2
17/11/2023
An in-depth look at the role of Transmission Electron Microscopy in a modern cellular pathology department. What technical challenges are there in preparing tissue for TEM and what diagnostic challenges does TEM have an important role in.
Transmission Electron Microscopy Webinar 3
22/11/2023
An in-depth look at Transmission Electron Microscopy in a modern cellular pathology department. How to prepare tissue for TEM and what diagnostic challenges does TEM have an important role in.
CONGRESS 2023 - Biomarkers, disease severity and triaging the role of mid-regional proadrenomodulin
28/09/2023
There is a lack of validated tools to assess potential disease progression and hospitalisation decisions in patients presenting to the emergency department (ED) with a suspected infection. The aim to identify suitable blood biomarkers (MR-proADM, PCT, lactate and CRP) and/ or clinical scores (SIRS, SOFA, qSOFA, NEWS and CRB-65) to fulfil this unmet clinical need and recognising the “ill looking well” and the “well looking ill”. We found in patients presenting to the ED with a suspected infection, the blood biomarker MR-proADM could most accurately identify the likelihood of further disease progression.
Incorporation into an early sepsis management protocol may therefore aid rapid decision-making in order to either initiate, escalate or intensify early treatment strategies, or identify patients suitable for safe out-patient treatment. There is currently a randomised controlled trial to assess the accuracy of the above findings.
Incorporation into an early sepsis management protocol may therefore aid rapid decision-making in order to either initiate, escalate or intensify early treatment strategies, or identify patients suitable for safe out-patient treatment. There is currently a randomised controlled trial to assess the accuracy of the above findings.
Page 6 of 46